Quantification of human serum procollagen C-proteinase enhancer (hsPCPE) glycopattern. 2011

Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
Metabolic Enzymatic Laboratory, Chaim Sheba Medical Center, Tel Hashomer, Israel.

BACKGROUND Procollagen C-proteinase enhancer 1 (PCPE1), a glycoprotein secreted from differentiating osteoblast, enhances the rate-limiting step of collagen type I fibrillar formation. It is expressed and secreted by cells that produce collagen type I and has the potential to be a marker for bone pathologies. METHODS We developed an assay to quantify PCPE glycopattern based on isoelectric focusing (IEF) and detection with a bio-imaging camera (coefficient of variation within and between assays, 15% and 20%, respectively). RESULTS PCPE was quantified in 39 serum samples from healthy subjects (17 females and 22 males). The concentration in the serum was 305(274) ng/ml, median(IQR). The level of the PCPE isoforms and their relative distribution were altered in patients with bone disorders. CONCLUSIONS The data generated by our system, support our hypothesis that combined data on PCPE concentration and isoforms may be useful for the diagnosis and follow-up of bone diseases. Further research, on larger cohorts of both normal subjects and patients, must be done.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001851 Bone Diseases, Metabolic Diseases that affect the METABOLIC PROCESSES of BONE TISSUE. Low Bone Density,Low Bone Mineral Density,Osteopenia,Metabolic Bone Diseases,Bone Density, Low,Bone Disease, Metabolic,Low Bone Densities,Metabolic Bone Disease,Osteopenias
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
May 2001, European journal of biochemistry,
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
October 2018, Structure (London, England : 1993),
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
May 2009, Clinica chimica acta; international journal of clinical chemistry,
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
November 2011, The Journal of biological chemistry,
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
January 1995, Methods in enzymology,
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
January 2019, Methods in molecular biology (Clifton, N.J.),
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
October 2018, Structure (London, England : 1993),
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
December 2022, Experimental eye research,
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
November 2022, International urology and nephrology,
Yael Olswang-Kuz, and Boaz Liberman, and Israel Weiss, and Eyal Ramu, and Rony Weitzen, and Iris Vered, and Galia Gat-Yablonski, and Efrat Kessler, and Yair Anikster, and Shlomit Mesilaty-Gross
April 1997, Matrix biology : journal of the International Society for Matrix Biology,
Copied contents to your clipboard!